Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

579 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aberrant expression of integrin and erbB subunits in breast cancer cell lines.
Shimizu H, Koyama N, Asada M, Yoshimatsu K. Shimizu H, et al. Among authors: asada m. Int J Oncol. 2002 Nov;21(5):1073-9. Int J Oncol. 2002. PMID: 12370757
Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models.
Ito K, Semba T, Uenaka T, Wakabayashi T, Asada M, Funahashi Y. Ito K, et al. Among authors: asada m. Cancer Sci. 2014 Aug;105(8):1023-31. doi: 10.1111/cas.12450. Cancer Sci. 2014. PMID: 24841832 Free PMC article.
E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models.
Nakagawa T, Tohyama O, Yamaguchi A, Matsushima T, Takahashi K, Funasaka S, Shirotori S, Asada M, Obaishi H. Nakagawa T, et al. Among authors: asada m. Cancer Sci. 2010 Jan;101(1):210-5. doi: 10.1111/j.1349-7006.2009.01343.x. Epub 2009 Sep 2. Cancer Sci. 2010. PMID: 19832844
Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
Matsui J, Funahashi Y, Uenaka T, Watanabe T, Tsuruoka A, Asada M. Matsui J, et al. Among authors: asada m. Clin Cancer Res. 2008 Sep 1;14(17):5459-65. doi: 10.1158/1078-0432.CCR-07-5270. Clin Cancer Res. 2008. PMID: 18765537
E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.
Matsui J, Yamamoto Y, Funahashi Y, Tsuruoka A, Watanabe T, Wakabayashi T, Uenaka T, Asada M. Matsui J, et al. Among authors: asada m. Int J Cancer. 2008 Feb 1;122(3):664-71. doi: 10.1002/ijc.23131. Int J Cancer. 2008. PMID: 17943726
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities.
Mizui Y, Sakai T, Iwata M, Uenaka T, Okamoto K, Shimizu H, Yamori T, Yoshimatsu K, Asada M. Mizui Y, et al. Among authors: asada m. J Antibiot (Tokyo). 2004 Mar;57(3):188-96. doi: 10.7164/antibiotics.57.188. J Antibiot (Tokyo). 2004. PMID: 15152804
An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model: possible value of integrin alpha2 on platelets as a biological marker.
Semba T, Funahashi Y, Ono N, Yamamoto Y, Sugi NH, Asada M, Yoshimatsu K, Wakabayashi T. Semba T, et al. Among authors: asada m. Clin Cancer Res. 2004 Feb 15;10(4):1430-8. doi: 10.1158/1078-0432.ccr-0109-03. Clin Cancer Res. 2004. PMID: 14977846
Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
Shimizu H, Seiki T, Asada M, Yoshimatsu K, Koyama N. Shimizu H, et al. Among authors: asada m. Oncogene. 2003 Feb 13;22(6):831-9. doi: 10.1038/sj.onc.1206203. Oncogene. 2003. PMID: 12584562
Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.
Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M. Ohtaki T, et al. Among authors: asada m. Nature. 2001 May 31;411(6837):613-7. doi: 10.1038/35079135. Nature. 2001. PMID: 11385580
Novel sulfonamides as potential, systemically active antitumor agents.
Yoshino H, Ueda N, Niijima J, Sugumi H, Kotake Y, Koyanagi N, Yoshimatsu K, Asada M, Watanabe T, Nagasu T, et al. Yoshino H, et al. Among authors: asada m. J Med Chem. 1992 Jun 26;35(13):2496-7. doi: 10.1021/jm00091a018. J Med Chem. 1992. PMID: 1619621 No abstract available.
579 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback